Menu ×


Pediatric Perfusion Products Market Segmentation By Product Type (Pediatric Centrifugal Blood Pumps, Pediatric Oxygenation Systems, Pediatric Cannulae, Arterial Filters, Hemoconcentrators, Extracorporeal Circuits, and Others); By End User (Hospitals, Homecare Settings, Ambulatory Surgical Centers and Clinics) - Global Demand Analysis & Opportunity Outlook 2028

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  •  January 3, 2020 – Masimo’s RD Set Sensors got clearance from the FDA. It features the company’s signature Measure-through Motion and Low Perfusion SET pulse oximetry, to exhibit much better accuracy while observing neonatal patients.

  • Perfusion Week 2020 – American Society of Extracorporeal Technology organizes PERFUSION WEEK every year to recognize the dedication of perfusionists around the world. This year April 27 marks the first day of Perfusion Week 2020.

  • February 27, 2020 – A team of researchers from Boston Children’s Hospital and Harvard developed an artificial valve that can be expanded and is comparatively cheaper to perform. Since various congenital surgeries require placement of prosthetic heart valves and as the heart grows with the infant’s age, valves have to be replaced through repeated surgeries which is altogether an expensive process.


Perfusion is the process of oxygenated blood being delivered to an organ or tissue of the body. Many neonates, infants, and children suffer from congenital heart defects (CHDs) and go through heart surgeries that need pediatric perfusion devices. These circulatory devices are mechanical support used in open-heart surgeries to bypass the blood from the lungs and heart and regulate the flow of blood. The perfusion system is also known as extracorporeal life support (ECLS) system.


The pediatric perfusion products market is anticipated to attain a notable CAGR during the forecast period, i.e., 2020-2028. The market is segmented by product type, end-user, and region. Among product segmentation, the pediatric cannulae segment is anticipated to hold the largest market share during the forecast period owing to an increasing prevalence of respiratory problems among new-borns, and consumers preferring cannulae as they are created soft and flexible that makes them suitable for neonatal use in high flow oxygen therapy.

Growth Drivers

Growing Rate of Cardiac Birth Defects

The rising cases of cardiac birth defects such as congenital heart diseases are primarily driving the growth of the market around the world. Congenital means present at birth.  According to March of Dime, Nearly 1 in every 100 babies is born with a heart defect in the United States each year and about 1 in every 4 babies born (about 25 percent) has a critical CHD.

Increasing Demand for Non-Invasive Treatment

The demand for non-invasive or minimally invasive treatments to cure heart defects has increased. According to the Centers for Disease Control and Prevention (CDC), 16,800 babies in the U.S. are born each year with ventricular septal defects (VSD) which have elevated the demand of the products.

Additionally, increasing awareness around the new treatment of different heart abnormalities, effective technological advancements, and rising acceptance of pediatric perfusion products among consumers are anticipated to expedite the demand for pediatric perfusion products during the forecast period.


High Cost

High cost accompanying pediatric cardiac heart surgeries in low-income nations might hamper the growth of the global pediatric perfusion products market during the forecast period.

Additionally, strict regulatory guidelines for pediatric perfusion devices and the lesser availability of pediatric heart surgeons and perfusionists are projected to hamper the growth of the global market. CLICK TO DOWNLOAD FREE SAMPLE 


Our in-depth analysis of the pediatric perfusion product market includes the following segments:

By Product

  • Pediatric Centrifugal Blood Pumps
  • Pediatric oxygenation systems
  • Pediatric Cannulae
  • Arterial Filters
  • Hemoconcentrators
  • Extracorporeal Circuits
  • Others

By End-User

  • Hospitals
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Clinics
  • Others

By Region

Geographically, the pediatric perfusion products market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.

North America captured the largest share of the global pediatric perfusion products market on account of high prevalence of congenital heart diseases in the U.S., increase in diagnosis rate of congenital heart diseases, high open heart surgery rate, and well-established health care infrastructure.

According to the Centers for Disease Control and Prevention (CDC), congenital heart diseases affect approximately 1% of the total pediatric population in the U.S. every year. The widespread presence of mild congenital heart diseases has increased in the country in the past five years, whereas the prevalence of critical congenital heart diseases has been stable.

Germany, the U.K., and France held the major shares of the pediatric perfusion market in Europe for the year 2018. This can be attributed to high rate of diagnosis and treatment of congenital heart diseases, highly developed health care industry, presence of ambulatory surgery centers and availability of sophisticated instruments in hospitals.

China and Japan attained dominant shares of the pediatric perfusion products market in the Asia Pacific region in 2018 owing to growing patient population, and soaring investments in research & development ventures by healthcare organisations. The market in India is estimated to expand at high growth in the next few years, owing to a large population of neonates and developing health care infrastructure. However, underdeveloped health care infrastructure and unavailability of skilled pediatric heart surgeons are some of the factors that might negatively affect the growth of the pediatric perfusion market in Latin America, the Middle East & Africa during the forecast period.

pediatric perfusion market Graph

The pediatric perfusion products market is further classified on the basis of region as follows:

•  North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis

•  Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis

•  Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis

•  Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis

•  Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Top Featured Companies Dominating The Market

Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved